Publications by authors named "Guiard-Schmid J"

Background: Suboptimal use of antibiotics is a driver of antimicrobial resistance (AMR). Clinical decision support systems (CDSS) can assist prescribers with rapid access to up-to-date information. In low- and middle-income countries (LMIC), the introduction of CDSS for antibiotic prescribing could have a measurable impact.

View Article and Find Full Text PDF

Objective: In 2014, the Joint United Nations Program on HIV and AIDS (UNAIDS) and partners set the '90-90-90 targets'. Many countries are facing the challenge of estimating the first 90. Our objective was to propose an alternative modelling procedure, and to discuss its usefulness for taking into account duplication.

View Article and Find Full Text PDF
Article Synopsis
  • * A study of 694 HIV-infected outpatients found that 14% had PTD, but common diagnostic markers were ineffective in accurately identifying it.
  • * Tenofovir disoproxil fumarate exposure was linked to PTD primarily in non-African patients, with only a small percentage experiencing a rapid decline in estimated glomerular filtration rate (eGFR) over time.
View Article and Find Full Text PDF

Background: Like many African countries, the issue of sex between men in Burkina Faso remains taboo and sometimes result in social exclusion. This population which is vulnerable to HIV/AIDS is unknown, due to lack of scientific researches.

Aim: Our study aimed to characterize knowledge, attitudes and sexual practices and to estimate HIV seroprevalence among men having sex with men (MSM) living in Ouagadougou.

View Article and Find Full Text PDF

Objective: To evaluate the vulnerability of male prisoners to HIV, risk behaviour and access to prevention.

Methods: This cross-sectional descriptive study was conducted in july and August 2012 in Ouagadougou Prison in Burkina Faso. Two trained investigators collected data by means of individual interviews in the prison visiting room using a questionnaire administered to male inmates 18 years and older, imprisoned for more than three months.

View Article and Find Full Text PDF

Introduction: Gender differences in antiretroviral therapy (ART) outcomes are critical in sub-Saharan Africa. We assessed the association between gender and virologic failure among adult patients treated in a public routine clinic (one of the largest in West Africa) in Burkina Faso.

Methods: We performed a case-control study between July and October 2012 among patients who had received ART at the Bobo Dioulasso Day Care Unit.

View Article and Find Full Text PDF

The aim of this survey was to assess the HIV risk practices of male prisoners and their access to prevention. This descriptive study took place at the House of Detention and Corrections in Ouagadougou from June through August 2012. In all, 165 prisoners (median age: 28 years, range: 18-65) were interviewed.

View Article and Find Full Text PDF

Objective: The authors had for aim to assess the prevalence of hepatitis B co-infection in a cohort of HIV-infected patients, routinely followed-up at the Day Care Unit of the Bobo Dioulasso Sanou Souro University Hospital, Burkina Faso.

Patients And Methods: The Elisa technique was used to dose HBs antigen (AgHBs), antibodies anti-HBs and anti-HBc in all the patients followed by the biological laboratory, from October to December 2008.

Results: The AgHBs prevalence was 12.

View Article and Find Full Text PDF

Background And Objectives: The therapy and outcome of HIV infection have dramatically changed over the last 15 years, resulting in a change in renal complications. This study analyzed the characteristics of HIV-infected patients and biopsy-proven tubulointerstitial nephropathies to define disease patterns and therapeutic implications.

Design, Setting, Participants, & Measurements: A clinico-pathologic retrospective study of 59 consecutive renal biopsies showing predominant tubular and/or interstitial lesions in HIV-infected patients referred to the nephrology department between 1995 and 2011 was performed.

View Article and Find Full Text PDF

We examined factors associated with virological failure in 310 HIV-infected patients receiving atazanavir (ATV). Independent links were identified with virological failure under ATV: virological failure previous history (P = 0.006) and ATV underdosing (P = 0.

View Article and Find Full Text PDF
Article Synopsis
  • Liver fibrosis assessment is crucial for deciding on hepatitis B treatment, with liver biopsy being the current gold standard in Burkina Faso.
  • A study involving 59 HBV-infected patients compared liver stiffness measurements (Fibroscan) and serum markers against liver biopsy results to evaluate fibrosis levels.
  • The findings indicate that alternative methods, particularly the combination of Fibroscan and serum markers, align well with biopsy results and could significantly reduce the need for biopsies by up to 80%, helping doctors determine which patients need treatment.
View Article and Find Full Text PDF

Objective: The goal of the study was to assess the activity of a multidisciplinary structure for HIV infected patients, two years after the opening of the day hospital.

Design: A retrospective observational study of the Bobo Dioulasso day-hospital was made using the ESOPE (Epiconcept, France) software.

Results: In 2002, 147 patients were followed in the Bobo Dioulasso university hospital, 27 (or 18.

View Article and Find Full Text PDF
Article Synopsis
  • Chagas disease (CD) is primarily found in Latin America, with Bolivia having the highest rates of infection.
  • It occasionally appears in the U.S. and Canada among Latin American migrants, but is uncommon in Europe.
  • The report highlights 9 cases of imported Chagas disease identified in France between 2004 and 2006.
View Article and Find Full Text PDF

Haematological anomalies are frequent during HIV infection, and can be the fact of virus and or bone marrow toxicity of antiretroviral drugs. In order to analyze the evolution of the haematological parameters during HAART this work was carried out in the internal medicine department of the national teaching hospital Yalgado-Ouédraogo in Ouagadougou. So 107 patients receiving for the first time HAART and followed regularly were retained.

View Article and Find Full Text PDF

In HIV/hepatitis C virus (HCV)-coinfected patients, it is recommended to repeat liver biopsy every 3 years when anti-HCV treatment is not indicated. We studied fibrosis progression in HIV/HCV-coinfected patients, who were not receiving anti-HCV treatment, on the basis of two successive liver biopsies. Thirty-two patients were retrospectively included.

View Article and Find Full Text PDF

HIV-infected patients who are on hemodialysis have a worse prognosis than noninfected patients who are on hemodialysis. Their outcome in the highly active antiretroviral therapy (HAART) era remains unclear. Outcomes in patients who were enrolled in the French Dialysis in HIV/AIDS (DIVA) cohort were determined in a 2-yr prospective follow-up.

View Article and Find Full Text PDF
Article Synopsis
  • * After initiating corticosteroids, she experienced renal failure and kidney enlargement, leading to a biopsy that confirmed acute interstitial nephritis, with no active infections found.
  • * Her treatment involved prednisone to manage the renal failure caused by IRIS, while her HIV treatment showed success through improved CD4+ cell counts and undetectable viral loads.
View Article and Find Full Text PDF

A review of the hospital charts for 788 patients treated in 19 public and private clinics in Cameroon showed that clinical follow-up visits, biologic follow-up visits, and drug supply were irregular and that many patients interrupted treatment. Virological and immunologic effectiveness of therapy was as expected in patients for whom results were available.

View Article and Find Full Text PDF
Article Synopsis
  • In 2002, a survey found that 0.67% of dialysis patients in France were HIV-infected, a significant increase from 0.38% in 1997.
  • The study included data from over 28,000 dialysis patients, with 39.8% of HIV patients experiencing kidney failure due to HIV-associated nephropathy.
  • Factors contributing to the rise in HIV prevalence included better access to dialysis and an increasing number of patients from Africa and the Caribbean, alongside effective antiretroviral therapy (ART) improving treatment outcomes.
View Article and Find Full Text PDF